PCell Bio Inc.
PCell uses plant cells as living factories inside vertical bioreactors to produce high-value biomolecules, including oral GLP-1 biologics bioencapsulated in lettuce and crocin, the active compound in saffron. The platform converts designed genetic constructs into GMP-ready therapeutics and food-grade actives through six integrated steps, eliminating cold-chain logistics and seasonal supply risks. Its crocin program produces the premium compound in weeks at a fraction of field costs, with consistent purity and zero pesticide use.
- Biotechnology
- Drug Discovery & Therapeutics
- Manufacturing / Industry 4.0
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Traditional biologic manufacturing relies on large-scale fermenters, cold-chain logistics, and injection-based delivery, creating high costs and accessibility barriers. Supply chains for premium plant-derived compounds like saffron are vulnerable to climate events, labor shortages, and seasonal variability, driving prices up to $3,600 per kilogram.
Solution
PCell grows plant cells as living factories inside vertical bioreactors to produce high-value biomolecules from designed genetic constructs. The platform uses six integrated steps—from genetic design to purification—to deliver GMP-ready therapeutics and food-grade actives. Its lead program produces GLP-1 agonists inside lettuce chloroplasts, where the plant cell wall protects the protein through the stomach for gut-lumen release without injections or cold-chain storage. A second program cultivates crocin, the active saffron compound, in weeks with consistent purity, traceability, and zero pesticide use.
Target Audience
Primary customers are pharmaceutical and nutraceutical companies seeking cost-effective production of complex biologics and rare plant-derived compounds, particularly those focused on metabolic disease therapies and premium ingredient supply chains.
Features
- Vertical plant-based bioreactors that stack yield without requiring industrial fermenters
- Chloroplast-targeted expression of GLP-1 biologics in edible lettuce for oral delivery without cold chain
- Programmable expression system that converts any designed genetic construct into a target biomolecule
- High-purity crocin production in weeks, independent of climate, labor, and seasonal cycles
- GMP-aligned, contaminant-free, traceable supply chain for nutraceutical and pharmaceutical applications
- Production process powered by light and water, with no fossil-derived carbon feedstocks